Solidcore Resources advances final exchange offer after shareholder approval

Vitaly Nesis Chief Executive Officer at Solidcore Resources Solidcore Resources
Vitaly Nesis Chief Executive Officer at Solidcore Resources - Solidcore Resources
0Comments

Solidcore Resources plc has announced that all resolutions at its recent General Meeting were approved, enabling the company to move forward with its Final Exchange Offer and a potential Mandatory Buyback of shares held in Euroclear. The announcement follows the disclosure made on 14 July 2025.

The company stated, “With this, the Company is now launching the Final Exchange Offer, to be followed, subject to the approval of the Board of Directors (the ‘Board’), by a procedure which will allow the Company to implement the Mandatory Buyback of all shares which continue to be held in Euroclear.”

Shareholders who hold their shares through Russia’s National Settlement Depository or indirectly under Euroclear via Russian depositories are being encouraged to exchange their holdings for AIX-issued shares on a one-for-one basis. Transfers must be completed by 31 October 2025. Details for Nominated Brokers can be found on Solidcore’s website within an FAQ document available at https://www.solidcore-resources.com/ru/corporate-action/.

For those holding shares in Euroclear through non-sanctioned brokers or depositories outside Russia and who have not yet transferred them to AIX, Solidcore urges completion of transfers via an AIX trading member or registrar by 31 October 2025.

Shares not tendered into the Final Exchange Offer and still held through Euroclear may be subject to a mandatory buyback at $2.57 per share as outlined in the Circular. According to Solidcore, “The Company does not intend to implement the Mandatory Buyback prior to completion of the Final Exchange Offer. Implementation of the Mandatory Buyback is in the Board’s absolute discretion.”

Further information about both procedures can be found in documents available at https://www.solidcore-resources.com/en/corporate-action/.

Key dates include:
– Announcement of General Meeting results and opening of Final Exchange Offer: 30 July 2025
– Deadline for transferring eligible shares: 31 October 2025
– Settlement date for last tranche/exchange offer close: on or before 28 November 2025
– Earliest possible start date for mandatory buyback process: on or after 3 November 2025

The company noted that these dates could change and any updates would be posted on its website.

Voting results from the General Meeting showed strong support across all resolutions related to off-market purchases under the exchange offer, changes to articles of association, restricted share disposal, and handling treasury shares connected with both actions. For each resolution, over 91% voted in favor.

Nominated Brokers may set earlier deadlines according to their own internal procedures.



Related

Paul Hudson Chief Executive Officer Sanofi SA

Acoziborole receives key EU panel backing as single-dose treatment for sleeping sickness

Acoziborole Winthrop, a new oral treatment for sleeping sickness developed by the Drugs for Neglected Diseases initiative (DNDi) and Sanofi, has received a positive opinion from the European Medicines Agency’s Committee for Medicinal Products for…

Martin Lundstedt President and CEO at Volvo Group North America LLC Volvo Group North America LLC

Volvo announces updated share and vote count after series conversion

The number of votes in AB Volvo has changed following the conversion of 2,000,619 Series A shares into an equal number of Series B shares.

Paul Hudson Chief Executive Officer Sanofi SA

Sanofi and Regeneron’s Dupixent recommended for EU approval in young children with chronic urticaria

Sanofi and Regeneron have announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending approval of Dupixent (dupilumab) for children aged two to 11 years with…

Trending

The Weekly Newsletter

Sign-up for the Weekly Newsletter from EU Business Daily.